Goldman Sachs maintains Neutral on Cytokinetics with consistent price target
Source
Discover more from Walk Seeing Guy - Asia
Subscribe to get the latest posts sent to your email.
Posted inStartup
Goldman Sachs maintains Neutral on Cytokinetics with consistent price target By Investing.com
Posted by
No Comments
No Comments
Post navigation
Previous Post
Apple Adds AI Writing to iPhone 16 for Texts, Emails